Sarah Boyce, President and CEO: Avidity Biosciences RNA Sell · Filed 24/06/20

Trade details

Type: Insider sale
Amount: $1,255,055.62
Shares · price: 32,074 sh · $39.13 a share
Held after: 142,543 sh
Stock: Avidity Biosciences RNA
Person: Sarah BoycePresident and CEO
Trade date: 24/06/18
Filed: 24/06/20
Days to filing: 2 days

Sold 18.4% of holdings

Share of holding sold: 18.4%

Avidity Biosciences trades, last 26 weeks

What else happened in Avidity Biosciences around then

Filed or reported within 30 days of the trade day · 24/05/19~24/07/18

Sarah Boyce's recent trades

Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$579.1K
7,993 sh
$579.1K
Filed 01/23
Traded 01/21
Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$463.2K
6,394 sh
$463.2K
Filed 01/23
Traded 01/21
Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$619.4K
8,576 sh
$619.4K
Filed 01/09
Traded 01/07
Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$2.5M
50,000 sh
$2.5M
Filed 25/09/05
Traded 25/09/05
Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$1.2M
25,000 sh
$1.2M
Filed 25/08/29
Traded 25/08/28